/PRNewswire/ Ademi LLP is investigating Syneos Health (Nasdaq: SYNH) for possible breaches of fiduciary duty and other violations of law in its transaction.
13.04.2023 - MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) - Syneos Health (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, will release its first quarter 2023 financial results on Wednesday, May 10th, 2023, prior to its .
Revenue for the fourth quarter of $1,359.9 million decreased 1.0% on a reported basis and increased 1.7% on a constant currency basis year-over-year.Clinical Solutions net new business awards and book-to-bill
03.01.2023 - MORRISVILLE, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) - Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Michelle Keefe is scheduled to present at the 41st .